121 related articles for article (PubMed ID: 38574273)
1. Constructing an Antibiotic-Free Protein Expression System for Ovalbumin Biosynthesis in Probiotic
Liu C; Lv X; Liu L; Li J; Du G; Chen J; Liu Y
J Agric Food Chem; 2024 Apr; 72(15):8693-8703. PubMed ID: 38574273
[TBL] [Abstract][Full Text] [Related]
2. Improved cryptic plasmids in probiotic Escherichia coli Nissle 1917 for antibiotic-free pathway engineering.
Dong MM; Song L; Xu JQ; Zhu L; Xiong LB; Wei DZ; Wang FQ
Appl Microbiol Biotechnol; 2023 Aug; 107(16):5257-5267. PubMed ID: 37405431
[TBL] [Abstract][Full Text] [Related]
3. Minimizing endogenous cryptic plasmids to construct antibiotic-free expression systems for
Zhou S; Zhao L; Zuo W; Zheng Y; Zhang P; Sun Y; Wang Y; Du G; Kang Z
Synth Syst Biotechnol; 2024 Mar; 9(1):165-175. PubMed ID: 38348398
[TBL] [Abstract][Full Text] [Related]
4. CRISPR-based curing and analysis of metabolic burden of cryptic plasmids in
Zainuddin HS; Bai Y; Mansell TJ
Eng Life Sci; 2019 Jun; 19(6):478-485. PubMed ID: 32625025
[No Abstract] [Full Text] [Related]
5. Expanding the toolbox of probiotic Escherichia coli Nissle 1917 for synthetic biology.
Ba F; Zhang Y; Ji X; Liu WQ; Ling S; Li J
Biotechnol J; 2024 Jan; 19(1):e2300327. PubMed ID: 37800393
[TBL] [Abstract][Full Text] [Related]
6. Construction of a new T7 promoter compatible Escherichia coli Nissle 1917 strain for recombinant production of heme-dependent proteins.
Fiege K; Frankenberg-Dinkel N
Microb Cell Fact; 2020 Oct; 19(1):190. PubMed ID: 33023596
[TBL] [Abstract][Full Text] [Related]
7. Construction of recombinant E. coli Nissle 1917 (EcN) strains for the expression and secretion of defensins.
Seo EJ; Weibel S; Wehkamp J; Oelschlaeger TA
Int J Med Microbiol; 2012 Nov; 302(6):276-87. PubMed ID: 22748509
[TBL] [Abstract][Full Text] [Related]
8. Probiotic Escherichia coli Nissle 1917 suppresses allergen-induced Th2 responses in the airways.
Bickert T; Trujillo-Vargas CM; Duechs M; Wohlleben G; Polte T; Hansen G; Oelschlaeger TA; Erb KJ
Int Arch Allergy Immunol; 2009; 149(3):219-30. PubMed ID: 19218814
[TBL] [Abstract][Full Text] [Related]
9. Integration of Multiple Phage Attachment Sites System to Create the Chromosomal T7 System for Protein Production in
Cheng SY; Lin TH; Chen PT
J Agric Food Chem; 2022 Aug; 70(33):10239-10247. PubMed ID: 35960546
[No Abstract] [Full Text] [Related]
10. The flagellin hypervariable region is a potential flagella display domain in probiotic Escherichia coli strain Nissle 1917.
Yang Y; Yang Y; Ou B; Xia P; Zhou M; Li L; Zhu G
Arch Microbiol; 2016 Sep; 198(7):603-10. PubMed ID: 27071621
[TBL] [Abstract][Full Text] [Related]
11. Genetic engineering of probiotic Escherichia coli Nissle 1917 for clinical application.
Ou B; Yang Y; Tham WL; Chen L; Guo J; Zhu G
Appl Microbiol Biotechnol; 2016 Oct; 100(20):8693-9. PubMed ID: 27640192
[TBL] [Abstract][Full Text] [Related]
12. Production of chicken ovalbumin in Escherichia coli.
Takahashi N; Orita T; Hirose M
Gene; 1995 Aug; 161(2):211-6. PubMed ID: 7665081
[TBL] [Abstract][Full Text] [Related]
13. High density fermentation of probiotic E. coli Nissle 1917 towards heparosan production, characterization, and modification.
Datta P; Fu L; Brodfuerer P; Dordick JS; Linhardt RJ
Appl Microbiol Biotechnol; 2021 Feb; 105(3):1051-1062. PubMed ID: 33481068
[TBL] [Abstract][Full Text] [Related]
14. Enhancing the antibacterial function of probiotic
Bartram E; Asai M; Gabant P; Wigneshweraraj S
Appl Environ Microbiol; 2023 Nov; 89(11):e0097523. PubMed ID: 37930328
[TBL] [Abstract][Full Text] [Related]
15. Plasmid Vectors for
Kan A; Gelfat I; Emani S; Praveschotinunt P; Joshi NS
ACS Synth Biol; 2021 Jan; 10(1):94-106. PubMed ID: 33301298
[No Abstract] [Full Text] [Related]
16. Engineering the probiotic bacterium Escherichia coli Nissle 1917 as an efficient cell factory for heparosan biosynthesis.
Hu S; Zhao L; Hu L; Xi X; Zhang Y; Wang Y; Chen J; Chen J; Kang Z
Enzyme Microb Technol; 2022 Aug; 158():110038. PubMed ID: 35453037
[TBL] [Abstract][Full Text] [Related]
17. Redesign of an Escherichia coli Nissle treatment for phenylketonuria using insulated genomic landing pads and genetic circuits to reduce burden.
Triassi AJ; Fields BD; Monahan CE; Means JM; Park Y; Doosthosseini H; Padmakumar JP; Isabella VM; Voigt CA
Cell Syst; 2023 Jun; 14(6):512-524.e12. PubMed ID: 37348465
[TBL] [Abstract][Full Text] [Related]
18. Engineering Escherichia coli for l-homoserine production.
Sun BY; Wang FQ; Zhao J; Tao XY; Liu M; Wei DZ
J Basic Microbiol; 2023 Feb; 63(2):168-178. PubMed ID: 36284486
[TBL] [Abstract][Full Text] [Related]
19. Probiotic Escherichia coli Nissle 1917 reduces growth, Shiga toxin expression, release and thus cytotoxicity of enterohemorrhagic Escherichia coli.
Mohsin M; Guenther S; Schierack P; Tedin K; Wieler LH
Int J Med Microbiol; 2015 Jan; 305(1):20-6. PubMed ID: 25465158
[TBL] [Abstract][Full Text] [Related]
20. Expression, purification, and functional analysis of an antigen-targeting fusion protein composed of CD40 ligand and the C-terminal fragment of ovalbumin.
Shi Y; Halperin SA; Lee SF
Protein Expr Purif; 2018 Feb; 142():37-44. PubMed ID: 28974444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
